Document is current
Any future updates will be listed below
-
Authors
Wang, Ruiqi
Chen, Yalin
Teopiz, Kayla M.
McIntyre, Roger S.
Cao, Bing
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (No. 32300926)
- License Information
-
More Information
Article History
Received: 14 April 2025
Accepted: 24 July 2025
First Online: 13 October 2025
Declarations
:
: The China Health and Retirement Longitudinal Study (CHARLS) received approval from the Ethical Review Committee of Peking University (IRB00001052-11015). The English Longitudinal Study of Ageing (ELSA) was approved by the London Multicentre Research Ethics Committee (MREC/01/2/91). The Health and Retirement Study (HRS) was approved by the Institutional Review Board at the University of Michigan and the National Institute on Aging (HUM00061128) and the Mexican Health and Aging Study (MHAS) is partly sponsored by the National Institutes of Health/National Institute on Aging (NIH R01AG018016) in the United States and the Instituto Nacional de Estadística y Geografía (INEGI) in Mexico. All respondents provided written informed consent.
: Not applicable.
: Dr. Roger S. McIntyre has received research grant support from CIHR/GACD/National Natural Science Foundation of China (NSFC) and the Milken Institute; speaker/consultation fees from Lundbeck, Janssen, Alkermes, Neumora Therapeutics, Boehringer Ingelheim, Sage, Biogen, Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine, Neurawell, Sunovion, Bausch Health, Axsome, Novo Nordisk, Kris, Sanofi, Eisai, Intra-Cellular, NewBridge Pharmaceuticals, Viatris, Abbvie and Atai Life Sciences. Kayla M. Teopiz has received fees from Braxia Scientific Corp.All other authors have no conflicts of interest to declare.
